Summary
Kineta Inc
Founded in 2008
Description
Next generation immunotherapies for cancer patients Kineta Inc. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class novel immunotherapies from discovery to proof of concept. Kineta is a clinical stage biotech...
Strengths
- Kineta Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Kineta Inc was founded, the company has grown faster than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Kineta Inc's annual revenue
$4324000
Based on Kona Equity data
-
Revenue per employee
$108100
-
Variance of revenue growth
0.11
-
Annual revenue growth since founding
$270250
-
Revenue growth rate from first known quarter to current
39.0%
Employee Count
40 employees
-
Employee growth rate from first known quarter to current
47.1%
G Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
3.92 M
-
Page views per visitor
2.0
-
Daily time
-
Location
Unlock unlimited leads
Similar Companies
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Cancer Targeted Technology LLC
cancertargetedtechnology.com- Founded in 2005
- Location: Woodinville, WA
- Annual Revenue: $5.8M
- Employees: 25
- Cancer Targeted Technology is a biotechnology company commercializing innovative small molecules that bind pivotal enzyme targets in cancer. The company designs and patents small molecular weight enzyme inhibitors with unique imaging and drug delivery ...
Centrexion Therapeutics
centrexion.com- Founded in 2013
- Location: Boston, MA
- Annual Revenue: $3.8M
- Employees: 17
- We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.
GlycoMimetics
glycomimetics.com- Founded in 2003
- Location: Rockville, MD
- Annual Revenue: $104.0K
- Employees: 52
- GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...
Pliant Therapeutics Inc
pliantrx.com- Founded in 2015
- Location: South San Francisco, CA
- Annual Revenue: $6.6M
- Employees: 101
- Pliant is a biotechnology company focused on developing breakthrough treatments for fibrotic diseases. They are dedicated to bringing hope to patients with fibrosis through the discovery and development of novel therapies. Pliant's approach involves ta...
Key Information
- Name: Kineta Inc
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 5417; 541
Disclaimer: These numbers are estimates and any other company information
is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona
Equity is in no way affiliated with Kineta Inc.
See similar companies
-
By City Seattle Small Biotechnology Company in Seattle Mid-size Biotechnology Company in Seattle Pharmaceuticals in Seattle Small Pharmaceuticals in Seattle Mid-size Pharmaceuticals in Seattle
-
By State WA Small companies in WA Pharmaceuticals in WA Small Pharmaceuticals in WA Mid-size Pharmaceuticals in WA Small Biotechnology Company in WA Mid-size Biotechnology Company in WA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 5 Founded in 2008 SIC: 80 SIC: 283 NAICS: 5417 NAICS: 541 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Where is Kineta Inc located?
Kineta Inc's headquarters are located at 219 TERRY Ave. N. Ste. 300 200 Seattle, WA 98109.
What is Kineta Inc's official website?
Kineta Inc's official website is kinetabio.com
What is Kineta Inc's revenue?
Kineta Inc's annual revenue is $4.3 M.
What is Kineta Inc's SIC code?
Kineta Inc's SIC: 80; 283
What is Kineta Inc's NAICS code?
Kineta Inc's NAICS: 5417; 541.
How many employees does Kineta Inc's have?
Kineta Inc has 40 employees
What industry does Kineta Inc belong to?
Kineta Inc is in the industry of Pharmaceuticals.
